Anthony Daniels is the Therapeutic Area Head Ocular Oncology at Aura. Dr. Daniels is responsible for leading the ocular oncology program and driving future strategy. He joins Aura from Vanderbilt University Medical Center, where he was on faculty for ten years and was Chief of the Division of Ocular Oncology. Dr. Daniels is a board-certified ophthalmologist who has treated ocular oncology patients for 15 years. At Vanderbilt, in addition to his very large clinical ocular oncology practice, he ran an ocular oncology drug development laboratory as an NIH-funded physician-scientist. He received an A.B. summa cum laude in Molecular Biology from Princeton, an M.Sc. in public health and health policy from the London School of Economics and Political Science (LSE), and an M.D. from the University of Pennsylvania School of Medicine, followed by an ophthalmology residency at Harvard, a vitreoretinal surgery fellowship at Harvard, and ocular oncology training at Memorial Sloan Kettering Cancer Center, at Mayo Clinic, and at Harvard.
Management